Timothy Yung-Cheng Chen is Director at BeiGene, Ltd. (BGNE). They have made 6 open-market trades across 1 company since 2019, most recently 2021-06-16.
CIK 0001374068
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BGNE | 7,800 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2021-06-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BGNE | SELL | 2021-06-09 | 2021-06-11 | $351.62 | $4.0M | -1.3% | -4.5% | -2.7% |
| BGNE | SELL | 2020-08-10 | 2020-08-12 | $212.92 | $1.5M | +12.8% | +18.6% | +34.2% |
| BGNE | SELL | 2019-11-05 | 2019-11-06 | $189.18 | $642K | +4.6% | -0.3% | -14.3% |
| BGNE | SELL | 2019-11-04 | 2019-11-06 | $190.01 | $2.5M | +4.6% | -0.3% | -14.3% |
| BGNE | SELL | 2019-11-04 | 2019-11-06 | $190.37 | $742K | +4.6% | -0.3% | -14.3% |
| BGNE | SELL | 2019-08-23 | 2019-08-27 | $144.98 | $2.4M | -10.6% | -8.7% | +46.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.